x

Posted 08 December, 2021

ICAD INC appointed new CEO

CEO Change detected for ticker Nasdaq:ICAD in a 8-K filed on 08 December, 2021.


  On December 6, 2021, Stacey M. Stevens was appointed Chief Executive Officer and President of iCAD, Inc. (the "Company"), effective March 1, 2022.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of ICAD INC
Technology • Computers/Consumer Electronics
iCAD, Inc. is a global medical technology company, which engages in the provision of cancer detection and therapy solutions. It operates through the Cancer Detection and Cancer Therapy segments. The Cancer Detection segment includes image analysis and workflow products. The Cancer Therapy segment relates to radiation therapy products. The company was founded in 1984 and is headquartered in Nashua, NH.
Market Cap
$59.7M
View Company Details
Relevant filing section
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. 

On December 6, 2021, Stacey M. Stevens was appointed Chief Executive Officer and President of iCAD, Inc. (the "Company"), effective March 1, 2022. Ms. Stevens has been with the Company since June 2006 and has most recently served as the Company's President since March 2019. Michael Klein, who currently serves as the Company's Chairman and Chief Executive Officer, will continue to serve as Chairman of the Company's Board of Directors following his resignation as Chief Executive Officer, effective March 1, 2022. 

Ms. Stevens is not a party to, and does not have any direct or indirect material interest in, any transaction requiring disclosure under Item 404(a) of Regulation S-K. Ms. Stevens' existing employment agreement as described in the Company's filings with the Securities and Exchange Commission will continue in effect until further notice. Mr. Klein's existing employment agreement will terminate on his resignation date of March 1, 2022. 

In addition to serving as the Company's President since March 2019, from February 2016 to March 2019, Ms. Stevens served as the Company's Executive Vice President, Chief Strategy and Commercial Officer, and from June 2006 to February 2016, she served as the Company's Senior Vice President of Marketing and Strategy. Prior to joining iCAD, Ms. Stevens held a number of sales, business development, and marketing management positions with Philips Medical Systems, Agilent Technologies, Inc. and Hewlett Packard's Healthcare Solutions Group (which was acquired in 2001 by Philips Medical Systems). From February 2005 to June 2006, she was Vice President, Marketing Planning at Philips Medical Systems, where she was responsible for the leadership of all global marketing planning functions for Philips' Healthcare Business. From 2003 to January 2005, she was Vice President of Marketing for the Cardiac and Monitoring Systems Business Unit of Philips, where she was responsible for all marketing and certain direct sales activities of Philips America's Field Operations. Prior to that, Ms. Stevens held several key marketing management positions in the Ultrasound Business Unit of Hewlett-Packard/Agilent and Philips Medical Systems. Ms. Stevens earned a Bachelor of Arts Degree in Political Science from the University of New Hampshire, and an MBA from Boston University's Questrom School of Management.